[
  {
    "generic_name": "Alprazolam",
    "brand_names": ["Xanax", "Alzam", "Restyl"],
    "active_ingredients": "Alprazolam 0.5mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7825",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Anxiolytic",
    "mechanism_of_action": "GABA-A receptor positive allosteric modulator",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Anxiety level, Sedation, Cognitive function, Dependence signs",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Acute narrow-angle glaucoma", "Severe respiratory insufficiency", "Sleep apnea", "Myasthenia gravis"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": true,
    "black_box_warning_text": "High dependence potential, severe withdrawal syndrome, respiratory depression when combined with opioids, cognitive impairment",
    "major_drug_interactions": ["Opioids (fatal respiratory depression)", "CNS depressants (severe sedation)", "CYP3A4 inhibitors (increased levels)", "Alcohol (severe CNS depression)"],
    "food_interactions": "Avoid alcohol, grapefruit juice",
    "search_keywords": ["alprazolam", "xanax", "anxiety", "panic disorder", "benzodiazepine"],
    "generic_variations": ["Alprazolam base"],
    "common_misspellings": ["Alprazalam", "Alprazolum", "Xanex"],
    "safer_alternatives": ["SSRIs (Sertraline, Escitalopram)", "Buspirone", "CBT therapy"],
    "cheaper_alternatives": ["Diazepam", "Lorazepam"],
    "notes": "Short-acting benzodiazepine. Very high abuse potential. Rapid dependence development. Taper slowly to avoid seizures. Not recommended for long-term use.",
    "is_active": true
  },
  {
    "generic_name": "Lorazepam",
    "brand_names": ["Ativan", "Loraz", "Temesta"],
    "active_ingredients": "Lorazepam 1mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7826",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": true,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Anxiolytic/Anticonvulsant",
    "mechanism_of_action": "GABA-A receptor positive modulator",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Anxiety level, Sedation, Cognitive function, Dependence signs",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Acute narrow-angle glaucoma", "Severe respiratory insufficiency", "Myasthenia gravis"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": true,
    "black_box_warning_text": "Dependence and withdrawal risk, respiratory depression with opioids, impaired cognition and memory",
    "major_drug_interactions": ["Opioids (respiratory depression)", "CNS depressants (enhanced sedation)", "Alcohol (severe CNS depression)", "Valproate (increased lorazepam levels)"],
    "food_interactions": "Avoid alcohol",
    "search_keywords": ["lorazepam", "ativan", "anxiety", "seizures", "benzodiazepine"],
    "generic_variations": ["Lorazepam base"],
    "common_misspellings": ["Lorazapam", "Lorazepem", "Ativan"],
    "safer_alternatives": ["SSRIs for anxiety", "Valproate for seizures", "Buspirone"],
    "cheaper_alternatives": ["Diazepam"],
    "notes": "Intermediate-acting benzodiazepine. Used for anxiety, status epilepticus, and premedication. Dependence risk with long-term use. Taper slowly to discontinue.",
    "is_active": true
  },
  {
    "generic_name": "Clonazepam",
    "brand_names": ["Rivotril", "Klonopin", "Clonotril"],
    "active_ingredients": "Clonazepam 0.5mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7827",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": true,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Anticonvulsant/Anxiolytic",
    "mechanism_of_action": "GABA-A receptor enhancer with anticonvulsant properties",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Seizure control, Sedation, Cognitive function, Dependence",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Acute narrow-angle glaucoma", "Severe respiratory disease", "Severe hepatic disease"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": true,
    "black_box_warning_text": "Risk of dependence and abuse, severe withdrawal syndrome including seizures, respiratory depression with opioids",
    "major_drug_interactions": ["Opioids (respiratory depression)", "CNS depressants (sedation)", "CYP3A4 inhibitors (increased levels)", "Alcohol (severe CNS depression)"],
    "food_interactions": "Avoid alcohol, grapefruit juice may increase levels",
    "search_keywords": ["clonazepam", "rivotril", "klonopin", "epilepsy", "panic disorder", "seizures"],
    "generic_variations": ["Clonazepam base"],
    "common_misspellings": ["Clonazapam", "Klonazepam", "Rivotrill"],
    "safer_alternatives": ["Valproate for seizures", "SSRIs for panic disorder", "Lamotrigine"],
    "cheaper_alternatives": ["Phenytoin for seizures", "Diazepam"],
    "notes": "Long-acting benzodiazepine. Used for epilepsy and panic disorder. Very difficult to discontinue - severe withdrawal seizures possible. Taper very slowly.",
    "is_active": true
  },
  {
    "generic_name": "Bromazepam",
    "brand_names": ["Lexotan", "Lectopam", "Lexilium"],
    "active_ingredients": "Bromazepam 3mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7828",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Anxiolytic",
    "mechanism_of_action": "GABA-A receptor positive modulator",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Anxiety symptoms, Sedation, Dependence signs",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Acute narrow-angle glaucoma", "Severe respiratory insufficiency", "Myasthenia gravis"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["Opioids (respiratory depression)", "CNS depressants (sedation)", "Alcohol (severe CNS depression)"],
    "food_interactions": "Avoid alcohol",
    "search_keywords": ["bromazepam", "lexotan", "anxiety", "benzodiazepine"],
    "generic_variations": ["Bromazepam base"],
    "common_misspellings": ["Bromazapam", "Bromezepam", "Lexoten"],
    "safer_alternatives": ["SSRIs", "Buspirone", "CBT therapy"],
    "cheaper_alternatives": ["Diazepam", "Lorazepam"],
    "notes": "Intermediate-acting benzodiazepine for anxiety. Popular in Nigeria but high dependence risk. Short-term use only recommended.",
    "is_active": true
  },
  {
    "generic_name": "Midazolam",
    "brand_names": ["Dormicum", "Versed", "Hypnovel"],
    "active_ingredients": "Midazolam HCl 5mg/ml",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7829",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": true,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 3,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Sedative/Anxiolytic",
    "mechanism_of_action": "GABA-A receptor positive modulator",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Respiratory rate, Sedation level, Blood pressure",
    "monitoring_frequency_days": 1,
    "addiction_risk": false,
    "abuse_potential": "moderate",
    "minimum_age": null,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Acute narrow-angle glaucoma", "Severe respiratory depression", "Shock"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": true,
    "black_box_warning_text": "Respiratory depression risk, must have resuscitation equipment available, trained personnel required for IV administration",
    "major_drug_interactions": ["Opioids (severe respiratory depression)", "CYP3A4 inhibitors (prolonged sedation)", "CNS depressants", "Alcohol"],
    "food_interactions": "Avoid grapefruit juice",
    "search_keywords": ["midazolam", "dormicum", "versed", "sedation", "anesthesia", "procedural sedation"],
    "generic_variations": ["Midazolam Hydrochloride"],
    "common_misspellings": ["Midazo lam", "Midazalam", "Dormicum"],
    "safer_alternatives": ["Propofol (for procedural sedation)", "Dexmedetomidine"],
    "cheaper_alternatives": ["Diazepam"],
    "notes": "Short-acting benzodiazepine for procedural sedation and anesthesia. Potent amnestic effects. Requires monitoring and resuscitation equipment. Hospital/clinic use primarily.",
    "is_active": true
  }
]
